原发性乳腺癌中与人表皮生长因子受体2过表达相关的锥光束乳腺CT特征
回顾性评估181例手术切除的原发性乳腺癌(排除三阴性)患者术前锥光束乳腺CT,HER2阳性101例(55.8%);多因素分析确认病理分级、最大径、分叶、ΔCT和钙化形态为HER2过表达的独立预测因素;CBBCT特征的AUC为0.853,优于临床病理特征(AUC=0.613,p<0.001),与两者联合相当(AUC=0.856,p=0.866)。
要点
- CBBCT特征可独立预测HER2状态,AUC=0.853。
- 病理分级、最大径、分叶、ΔCT和钙化形态是HER2过表达的独立预测因素。
- CBBCT特征判别HER2+/−优于临床病理特征(AUC 0.853 vs 0.613,p<0.001)。
关键影像表现/征象
- 钙化和边缘相关特征对区分HER2状态最重要(主成分分析)。
- CBBCT描述符包括最大径、分叶、ΔCT和钙化形态等,由共识双读半定量评估,读者间一致性高。
诊断标准与关键数值
- HER2阳性101/181例(55.8%)。
- 多因素分析确认病理分级、最大径、分叶、ΔCT和钙化形态为HER2/neu过表达的独立预测因素。
- CBBCT特征预测HER2状态的AUC=0.853,优于临床病理特征(AUC=0.613,p<0.001),与两者联合相当(AUC=0.856,p=0.866)。
临床应用与阅片要点
- 作者认为CBBCT特征可能补充组织病理学结果并有助于指导活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify the relationship between human epidermal growth factor receptor 2 (HER2) status and cone-beam breast CT (CBBCT) characteristics in surgically resected breast cancer.
METHODS: Preoperative CBBCT of patients with BI-RADS 4 or 5 lesions identified on mammography or ultrasound and dense or very dense breast tissue were retrospectively evaluated in 181 surgically resected breast cancer (triple-negative excluded) between May 2012 and November 2014. A set of CBBCT descriptors was semiquantitatively assessed by consensus double reading. Reader reproducibility was analyzed. Multivariable logistic regression analysis using backward elimination (BEA) with the Wald criterion was performed to identify independent predictive factors of harboring HER2/neu. Principle component analysis (PCA) was used to determine characteristics that might differentiate HER2 status. Receiver operating characteristic (ROC) curve analyses were conducted to determine the predictive capability.
RESULTS: HER2 positive was found in 101 (55.8%) of 181 patients. Inter-observer agreement was high for characteristics' assessment. Based on BEA, pathologic grade, maximum dimension, lobulation, ΔCT, and calcification morphology were confirmed as independent predictive factors of HER2/neu overexpression. PCA showed that calcification- and border-related characteristics were the most important for differentiation. ROC curve analyses showed that CBBCT features (AUC = 0.853) were superior to clinicopathologic features (AUC = 0.613, p < 0.001) and comparable with combination (AUC = 0.856, p = 0.866).
CONCLUSIONS: CBBCT features could be used to prognosticate HER2 status independently, which are potentially complementary to histopathologic result and helpful in guiding biopsy.
KEY POINTS: • Dmax, lobulation, ΔCT, and calcification morphology are independent predictors of HER2 status. • CBBCT features are superior to clinicopathologic features in HER2+/- discrimination. • CBBCT features are comparable with combination with clinicopathologic features in HER2+/- discrimination.
引用
- Zhu Y, Zhang Y, Ma Y, et al. Cone-beam breast CT features associated with HER2/neu overexpression in patients with primary breast cancer. Eur Radiol. 2020. PMID: 31900700. doi:10.1007/s00330-019-06587-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。